Stockscreener 앱 받기
1.47
3.52%
0.05
전일 마감가:
$1.42
열려 있는:
$1.47
하루 거래량:
2.31M
Relative Volume:
3.59
시가총액:
$48.79M
수익:
-
순이익/손실:
$-98.79M
주가수익비율:
-0.4495
EPS:
-3.27
순현금흐름:
$-51.66M
1주 성능:
+119.57%
1개월 성능:
+148.98%
6개월 성능:
+476.47%
1년 성능:
-46.35%
1일 변동 폭
$1.33
$1.74
1주일 범위
$0.6303
$1.74
52주 변동 폭
$0.2404
$3.98
Relmada Therapeutics Inc Stock (RLMD) Company Profile
명칭
Relmada Therapeutics Inc
전화
646 876 3459
주소
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
RLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 3.03 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.42 | 2.19B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.40 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.4801 | 111.01M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3333 | 672.88M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.1605 | 0 | 0 | 0 | 0 | 0.00 |
Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-09-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-06-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-10-14 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-14 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-11-18 | 개시 | Mizuho | Buy |
| 2021-05-20 | 재개 | Goldman | Buy |
| 2020-10-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-04 | 개시 | SunTrust | Buy |
| 2020-04-21 | 개시 | Goldman | Buy |
| 2020-01-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-12-16 | 개시 | Guggenheim | Buy |
모두보기
Relmada Therapeutics Inc 주식(RLMD)의 최신 뉴스
Exclusive: Relmada CEO says his recent buy reflects ’significant undervaluation’ - Investing.com
Leading vs lagging indicators on Relmada Therapeutics Inc. performanceWeekly Trade Recap & Risk Controlled Swing Alerts - Newser
Relmada Therapeutics Inc. Price Targets Raised After ReboundGap Up & Weekly High Momentum Picks - beatles.ru
Analyzing recovery setups for Relmada Therapeutics Inc. investorsJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - Newser
Will Relmada Therapeutics Inc. continue its uptrendShort Setup & Smart Money Movement Alerts - Newser
Is Relmada Therapeutics Inc. trending in predictive chart modelsJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Published on: 2025-09-03 14:56:26 - khodrobank.com
Published on: 2025-09-03 04:51:26 - Newser
Real time scanner hits for Relmada Therapeutics Inc. explained2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Analyzing drawdowns of Relmada Therapeutics Inc. with statistical toolsMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
How sentiment analysis helps forecast Relmada Therapeutics Inc.Jobs Report & Community Consensus Trade Signals - Newser
Can technical indicators confirm Relmada Therapeutics Inc.’s reversalMarket Risk Report & Safe Entry Momentum Tips - Newser
Is now a turning point for Relmada Therapeutics Inc.July 2025 Movers & High Accuracy Swing Entry Alerts - Newser
How to integrate Relmada Therapeutics Inc. into portfolio analysis tools2025 Risk Factors & Real-Time Stock Entry Alerts - Newser
Using R and stats models for Relmada Therapeutics Inc. forecasting2025 Short Interest & Daily Volume Surge Trade Alerts - Newser
Can machine learning forecast Relmada Therapeutics Inc. recoveryJuly 2025 Opening Moves & Safe Entry Zone Tips - Newser
Can Relmada Therapeutics Inc. be recession proofQuarterly Portfolio Review & Capital Efficiency Focused Ideas - khodrobank.com
What is Relmada Therapeutics Inc. s revenue forecastJuly 2025 Pullbacks & Short-Term High Return Ideas - khodrobank.com
What is Relmada Therapeutics Inc. s P E ratio telling us2025 Buyback Activity & Risk Managed Trade Strategies - khodrobank.com
Can momentum traders help lift Relmada Therapeutics Inc.Portfolio Return Report & Free Accurate Trade Setup Notifications - Newser
Relmada Therapeutics executive purchases 55,000 shares on open market - Investing.com
Relmada Therapeutics CMO Purchases 55,000 Shares - TipRanks
What the charts say about Relmada Therapeutics Inc. today2025 Historical Comparison & Weekly Top Gainers Trade List - Newser
What’s next for Relmada Therapeutics Inc. stock priceMarket Performance Report & Real-Time Buy Zone Alerts - Newser
Relmada Therapeutics (RLMD): Is the 91% Response Rate in Bladder Cancer a Catalyst for a Phase 3-Driven Bull Run? - AInvest
Will Relmada Therapeutics Inc. see short term momentumOptions Play & Low Volatility Stock Recommendations - Newser
Relmada Therapeutics, Inc. (RLMD) Reports 91% Response Rate in Phase 2 Bladder Cancer Study - Yahoo Finance
Is Relmada Therapeutics Inc.’s growth already priced inQuarterly Growth Report & Fast Moving Trade Plans - kpenews.com
Should value investors consider Relmada Therapeutics Inc.2025 Year in Review & Safe Entry Momentum Stock Tips - khodrobank.com
Is Relmada Therapeutics Inc. still worth holding after the dip2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
What MACD signals say about Relmada Therapeutics Inc.Analyst Downgrade & Risk Controlled Daily Plans - Newser
Unraveling the Sudden Surge in Relmada Therapeutics (RLMD.O): What's Really Behind the 44.5% Intraday Jump? - AInvest
Relmada Therapeutics (RLMD.O) Surges 44.5% Intraday: Unraveling the Hidden Driver - AInvest
RLMD.O Soars 44.5%—What’s Behind the Surge? - AInvest
3 Promising Penny Stocks With Market Caps Under $400M - Yahoo Finance
Is a relief rally coming for Relmada Therapeutics Inc. holdersFed Meeting & Risk Managed Investment Entry Signals - Newser
Price momentum metrics for Relmada Therapeutics Inc. explainedWeekly Market Outlook & Expert Verified Stock Movement Alerts - Newser
Will Breakout in Relmada Therapeutics Inc. Sustain Through Next Week getLinesFromResByArray error: size == 0 - kangso.co.kr
Best data tools to analyze Relmada Therapeutics Inc. stockInflation Watch & Low Volatility Stock Recommendations - Newser
Relmada Therapeutics Stock (RLMD) Opinions on Clinical Trial Results and Insider Buying - Quiver Quantitative
AI Tools Suggest Relmada Therapeutics Inc. May Outperform This Week2025 Momentum Check & Consistent Profit Trade Alerts - beatles.ru
Is it too late to sell Relmada Therapeutics Inc.Rate Hike & Weekly Watchlist of Top Performers - Newser
Analyzing Relmada Therapeutics Inc. with multi timeframe chartsStop Loss & Fast Momentum Entry Tips - Newser
Historical volatility pattern of Relmada Therapeutics Inc. visualizedPortfolio Performance Report & Pattern Based Trade Signal System - Newser
Relmada Therapeutics Inc (RLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Relmada Therapeutics Inc 주식 (RLMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TRAVERSA SERGIO | Chief Executive Officer |
Aug 26 '25 |
Buy |
0.62 |
80,545 |
49,938 |
814,569 |
| TRAVERSA SERGIO | Chief Executive Officer |
Aug 28 '25 |
Buy |
0.74 |
55,976 |
41,422 |
1,000,000 |
| Kelly Paul Edward | Chief Operating Officer |
May 16 '25 |
Buy |
0.43 |
200,000 |
86,060 |
412,295 |
| Shenouda Maged | Chief Financial Officer |
May 19 '25 |
Buy |
0.49 |
90,000 |
43,686 |
228,335 |
| Shenouda Maged | Chief Financial Officer |
May 20 '25 |
Buy |
0.52 |
60,000 |
31,422 |
288,335 |
| Shenouda Maged | Chief Financial Officer |
May 16 '25 |
Buy |
0.44 |
50,000 |
22,100 |
138,335 |
| Ence Chuck | CA and CO |
May 16 '25 |
Buy |
0.45 |
228,961 |
103,330 |
267,931 |
| TRAVERSA SERGIO | Chief Executive Officer |
May 20 '25 |
Buy |
0.56 |
147,686 |
82,246 |
734,024 |
| TRAVERSA SERGIO | Chief Executive Officer |
May 16 '25 |
Buy |
0.45 |
172,314 |
77,472 |
556,338 |
| TRAVERSA SERGIO | Chief Executive Officer |
May 19 '25 |
Buy |
0.50 |
30,000 |
14,994 |
586,338 |
1.14%
1.34%
자본화:
|
볼륨(24시간):